These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10501855)

  • 21. Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.
    Vestrheim AC; Moen A; Egge-Jacobsen W; Bratlie DB; Michaelsen TE
    Scand J Immunol; 2013 May; 77(5):419-28. PubMed ID: 23488770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen.
    Oppezzo P; Osinaga E; Tello D; Bay S; Cantacuzene D; Irigoín F; Ferreira A; Roseto A; Cayota A; Alzari P; Pritsch O
    Hybridoma; 2000 Jun; 19(3):229-39. PubMed ID: 10952411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids.
    Sandlie I; Aase A; Westby C; Michaelsen TE
    Eur J Immunol; 1989 Sep; 19(9):1599-603. PubMed ID: 2792180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
    Velders MP; Litvinov SV; Warnaar SO; Gorter A; Fleuren GJ; Zurawski VR; Coney LR
    Cancer Res; 1994 Apr; 54(7):1753-9. PubMed ID: 8137290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor targeting IgG3 triggers complement-mediated lysis of decay-accelerating factor expressing tumor cells through the alternative pathway amplification loop.
    Rösner T; Lohse S; Peipp M; Valerius T; Derer S
    J Immunol; 2014 Aug; 193(3):1485-95. PubMed ID: 24973443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses.
    Shaw DR; Khazaeli MB; LoBuglio AF
    J Natl Cancer Inst; 1988 Dec; 80(19):1553-9. PubMed ID: 3143014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
    Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2553. PubMed ID: 30524421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of neutralizing recombinant human antibodies against Varicella Zoster virus for use as a potential prophylactic.
    Lloyd-Evans P; Gilmour JE
    Hybridoma; 2000 Apr; 19(2):143-9. PubMed ID: 10868794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological characterization of a chimeric mouse-human IgM antibody directed against the 17-1A antigen.
    Fogler WE; Sun LK; Klinger MR; Ghrayeb J; Daddona PE
    Cancer Immunol Immunother; 1989; 30(1):43-50. PubMed ID: 2598174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.
    Redpath S; Michaelsen T; Sandlie I; Clark MR
    Immunology; 1998 Apr; 93(4):595-600. PubMed ID: 9659234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones.
    Chen S; Caragine T; Cheung NK; Tomlinson S
    Am J Pathol; 2000 Mar; 156(3):1085-91. PubMed ID: 10702424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of the hinge region length in binding of human IgG to human Fcgamma receptors.
    Redpath S; Michaelsen TE; Sandlie I; Clark MR
    Hum Immunol; 1998 Nov; 59(11):720-7. PubMed ID: 9796740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abundant tyrosine residues in the antigen binding site in anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: Application to radiolabeling.
    Olafsen T; Bruland OS; Zalutsky MR; Sandlie I
    Acta Oncol; 1996; 35(3):297-301. PubMed ID: 8679259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
    Price MR; Pimm MV; Baldwin RW
    Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2.
    Sutton VR; Burgess J; Pietersz GA; Li WJ; McKenzie IF; Trapani JA
    Ther Immunol; 1994 Apr; 1(2):83-93. PubMed ID: 7584487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing.
    Dechant M; Vidarsson G; Stockmeyer B; Repp R; Glennie MJ; Gramatzki M; van De Winkel JG; Valerius T
    Blood; 2002 Dec; 100(13):4574-80. PubMed ID: 12393717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors.
    Ding JW; Zhou T; Zeng H; Ma L; Verbeek JS; Yin D; Shen J; Chong AS
    J Immunol; 2008 Jan; 180(1):261-8. PubMed ID: 18097027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
    Welt S; Carswell EA; Vogel CW; Oettgen HF; Old LJ
    Clin Immunol Immunopathol; 1987 Nov; 45(2):214-29. PubMed ID: 3665201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.